MAPT and Alzheimer disease: Compiling GWAS evidence indicated that variants in BIN1 increase AD risk (Kingwell, 2013; Franzmeier et al., 2019), and its variants have been proven to be associated with only tau loads but not Aβ loads in AD brains (Chapuis et al., 2013).